{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:47:04Z","timestamp":1790027224733,"version":"4.0.1"},"reference-count":191,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005116","name":"Jawaharlal Nehru Centre for Advanced Scientific Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005116","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Department of Biotechnology, Department of Science and Technology, Government of India"},{"DOI":"10.13039\/501100001852","name":"CEFIPRA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001852","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.phrs.2018.04.014","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T16:34:04Z","timestamp":1524242044000},"page":"135-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Epigenetic modulation by small molecule compounds for neurodegenerative disorders"],"prefix":"10.1016","volume":"132","author":[{"given":"Akash Kumar","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarmistha","family":"Halder-Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Clement","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapas K.","family":"Kundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2018.04.014_bib0005","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.biochem.67.1.545","article-title":"Alteration of nucleosome structure as a mechanism of transcriptional regulation","volume":"67","author":"Workman","year":"1998","journal-title":"Annu. Rev. Biochem."},{"issue":"7","key":"10.1016\/j.phrs.2018.04.014_bib0010","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1101\/gad.1787609","article-title":"An operational definition of epigenetics","volume":"23","author":"Berger","year":"2009","journal-title":"Genes Dev."},{"issue":"5","key":"10.1016\/j.phrs.2018.04.014_bib0015","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/cne.21974","article-title":"Equal numbers of neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate brain","volume":"513","author":"Azevedo","year":"2009","journal-title":"J. Comp. Neurol."},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11065-010-9148-4","article-title":"The basics of brain development","volume":"20","author":"Stiles","year":"2010","journal-title":"Neuropsychol. Rev."},{"issue":"11","key":"10.1016\/j.phrs.2018.04.014_bib0025","doi-asserted-by":"crossref","first-page":"783","DOI":"10.14348\/molcells.2016.0233","article-title":"Epigenetic changes in neurodegenerative diseases","volume":"39","author":"Kwon","year":"2016","journal-title":"Mol. Cells"},{"key":"10.1016\/j.phrs.2018.04.014_bib0030","first-page":"58","article-title":"Epigenetic mechanisms in neurological and neurodegenerative diseases","volume":"9","author":"Landgrave-Gomez","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"10","key":"10.1016\/j.phrs.2018.04.014_bib0035","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nbt.1678","article-title":"Epigenetic modifications as therapeutic targets","volume":"28","author":"Kelly","year":"2010","journal-title":"Nat. Biotechnol."},{"issue":"4173","key":"10.1016\/j.phrs.2018.04.014_bib0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.1111098","article-title":"DNA modification mechanisms and gene activity during development","volume":"187","author":"Holliday","year":"1975","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0021-9258(18)57261-6","article-title":"The quantitative separation of purines, pyrimidines, and nucleosides by paper chromatography","volume":"175","author":"Hotchkiss","year":"1948","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1152\/japplphysiol.00238.2010","article-title":"Epigenetic alterations in aging","volume":"109","author":"Gonzalo","year":"2010","journal-title":"J. Appl. Physiol. (1985)"},{"issue":"5929","key":"10.1016\/j.phrs.2018.04.014_bib0055","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1126\/science.1170116","article-title":"Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1","volume":"324","author":"Tahiliani","year":"2009","journal-title":"Science"},{"issue":"5917","key":"10.1016\/j.phrs.2018.04.014_bib0060","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1126\/science.1166859","article-title":"Neuronal activity-induced Gadd45b promotes epigenetic DNA demethylation and adult neurogenesis","volume":"323","author":"Ma","year":"2009","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0065","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nn.2560","article-title":"Cortical DNA methylation maintains remote memory","volume":"13","author":"Miller","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0070","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neuron.2007.02.022","article-title":"Covalent modification of DNA regulates memory formation","volume":"53","author":"Miller","year":"2007","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0075","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.2514","article-title":"Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons","volume":"13","author":"Feng","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0080","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.neuron.2013.08.003","article-title":"Tet1 is critical for neuronal activity-regulated gene expression and memory extinction","volume":"79","author":"Rudenko","year":"2013","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0085","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.gde.2006.04.009","article-title":"MeCP2 dysfunction in Rett syndrome and related disorders","volume":"16","author":"Moretti","year":"2006","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0090","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s13311-013-0227-0","article-title":"Epigenetics, autism spectrum, and neurodevelopmental disorders","volume":"10","author":"Rangasamy","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn.2017.46","article-title":"The emerging field of epigenetics in neurodegeneration and neuroprotection","volume":"18","author":"Hwang","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.phrs.2018.04.014_bib0100","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fnagi.2013.00085","article-title":"DNA methylation, a hand behind neurodegenerative diseases","volume":"5","author":"Lu","year":"2013","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.phrs.2018.04.014_bib0105","doi-asserted-by":"crossref","first-page":"e6617","DOI":"10.1371\/journal.pone.0006617","article-title":"Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer\u2019s disease","volume":"4","author":"Mastroeni","year":"2009","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.phrs.2018.04.014_bib0110","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.neurobiolaging.2013.02.021","article-title":"Consistent decrease in global DNA methylation and hydroxymethylation in the hippocampus of Alzheimer\u2019s disease patients","volume":"34","author":"Chouliaras","year":"2013","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JAD-2012-111223","article-title":"Genome-wide DNA methylation differences between late-onset Alzheimer\u2019s disease and cognitively normal controls in human frontal cortex","volume":"29","author":"Bakulski","year":"2012","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.phrs.2018.04.014_bib0120","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1038\/tp.2012.55","article-title":"Epigenetic modifications in frontal cortex from Alzheimer\u2019s disease and bipolar disorder patients","volume":"2","author":"Rao","year":"2012","journal-title":"Transl. Psychiatry"},{"issue":"18","key":"10.1016\/j.phrs.2018.04.014_bib0125","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1523\/JNEUROSCI.6119-09.2010","article-title":"Methylation regulates alpha-synuclein expression and is decreased in Parkinson\u2019s disease patients\u2019 brains","volume":"30","author":"Jowaed","year":"2010","journal-title":"J. Neurosci."},{"issue":"11","key":"10.1016\/j.phrs.2018.04.014_bib0130","doi-asserted-by":"crossref","first-page":"9031","DOI":"10.1074\/jbc.C110.212589","article-title":"Alpha-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases","volume":"286","author":"Desplats","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"17","key":"10.1016\/j.phrs.2018.04.014_bib0135","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/hmg\/11.17.1911","article-title":"Dysregulation of gene expression in the R6\/2 model of polyglutamine disease: parallel changes in muscle and brain","volume":"11","author":"Luthi-Carter","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"15","key":"10.1016\/j.phrs.2018.04.014_bib0140","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/mds.22477","article-title":"Gene expression changes in blood as a putative biomarker for Huntington\u2019s disease","volume":"24","author":"Lovrecic","year":"2009","journal-title":"Mov. Disord."},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0145","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/hmg\/ddl013","article-title":"Regional and cellular gene expression changes in human Huntington\u2019s disease brain","volume":"15","author":"Hodges","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2018.04.014_bib0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neulet.2015.10.060","article-title":"DNA methylation in Huntington\u2019s disease: implications for transgenerational effects","volume":"625","author":"Thomas","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0155","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1073\/pnas.1221292110","article-title":"Extensive changes in DNA methylation are associated with expression of mutant huntingtin","volume":"110","author":"Ng","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.phrs.2018.04.014_bib0160","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1093\/hmg\/ddw076","article-title":"DNA methylation profiling in human Huntington\u2019s disease brain","volume":"25","author":"De Souza","year":"2016","journal-title":"Hum. Mol. Genet."},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s12017-013-8219-0","article-title":"Increased 5-methylcytosine and decreased 5-hydroxymethylcytosine levels are associated with reduced striatal A2AR levels in Huntington\u2019s disease","volume":"15","author":"Villar-Menendez","year":"2013","journal-title":"Neuromol. Med."},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0170","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1073\/pnas.55.4.805","article-title":"RNA synthesis and histone acetylation during the course of gene activation in lymphocytes","volume":"55","author":"Pogo","year":"1966","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0175","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1016\/j.cell.2014.09.037","article-title":"SnapShot: histone modifications","volume":"159","author":"Huang","year":"2014","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0180","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1086\/429130","article-title":"Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease","volume":"76","author":"Roelfsema","year":"2005","journal-title":"Am. J. Hum. Genet."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0185","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1101\/lm.1939811","article-title":"Subregion-specific p300 conditional knock-out mice exhibit long-term memory impairments","volume":"18","author":"Oliveira","year":"2011","journal-title":"Learn. Mem."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0092-8674(00)81165-4","article-title":"Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300","volume":"93","author":"Yao","year":"1998","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.phrs.2018.04.014_bib0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18071404","article-title":"Histone lysine methylation and neurodevelopmental disorders","volume":"18","author":"Kim","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2018.04.014_bib0200","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00401-003-0684-3","article-title":"Ectopic localization of phosphorylated histone H3 in Alzheimer\u2019s disease: a mitotic catastrophe?","volume":"105","author":"Ogawa","year":"2003","journal-title":"Acta Neuropathol."},{"issue":"20","key":"10.1016\/j.phrs.2018.04.014_bib0205","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","article-title":"Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity","volume":"15","author":"Kontopoulos","year":"2006","journal-title":"Hum. Mol. Genet."},{"issue":"5837","key":"10.1016\/j.phrs.2018.04.014_bib0210","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","article-title":"Kazantsev AG: Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson\u2019s disease","volume":"317","author":"Outeiro","year":"2007","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.phrs.2018.04.014_bib0215","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1074\/jbc.M115.675488","article-title":"Regulation of histone acetylation by autophagy in parkinson disease","volume":"291","author":"Park","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2018.04.014_bib0220","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neulet.2016.05.060","article-title":"Histone H3 acetylation in the postmortem Parkinson\u2019s disease primary motor cortex","volume":"627","author":"Gebremedhin","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2018.04.014_bib0225","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.neuropharm.2014.07.012","article-title":"Neuroprotective and neurotrophic effects of Apigenin and Luteolin in MPTP induced parkinsonism in mice","volume":"86","author":"Patil","year":"2014","journal-title":"Neuropharmacology"},{"issue":"6857","key":"10.1016\/j.phrs.2018.04.014_bib0230","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","author":"Steffan","year":"2001","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0235","first-page":"560","article-title":"Mutant huntingtin represses CBP, but not p300, by binding and protein degradation","volume":"30","author":"Cong","year":"2005","journal-title":"Mol. Cell. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/hmg\/ddg002","article-title":"Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein","volume":"12","author":"Jiang","year":"2003","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0245","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"issue":"50","key":"10.1016\/j.phrs.2018.04.014_bib0250","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","article-title":"ESET\/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington\u2019s disease","volume":"103","author":"Ryu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"23","key":"10.1016\/j.phrs.2018.04.014_bib0255","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1093\/hmg\/ddn273","article-title":"Inhibition of specific HDACs and sirtuins suppresses pathogenesis in a Drosophila model of Huntington\u2019s disease","volume":"17","author":"Pallos","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"11","key":"10.1016\/j.phrs.2018.04.014_bib0260","doi-asserted-by":"crossref","first-page":"e27746","DOI":"10.1371\/journal.pone.0027746","article-title":"SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington\u2019s disease","volume":"6","author":"Mielcarek","year":"2011","journal-title":"PLoS One"},{"issue":"40","key":"10.1016\/j.phrs.2018.04.014_bib0265","doi-asserted-by":"crossref","first-page":"15564","DOI":"10.1073\/pnas.0804249105","article-title":"The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington\u2019s disease transgenic mice","volume":"105","author":"Thomas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.phrs.2018.04.014_bib0270","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/hmg\/ddu010","article-title":"A potent and selective Sirtuin 1 inhibitor alleviates pathology in multiple animal and cell models of Huntington\u2019s disease","volume":"23","author":"Smith","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0275","doi-asserted-by":"crossref","first-page":"e0152498","DOI":"10.1371\/journal.pone.0152498","article-title":"The effects of pharmacological inhibition of histone deacetylase 3 (HDAC3) in huntington\u2019s disease mice","volume":"11","author":"Jia","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.04.014_bib0280","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/B978-0-12-415795-8.00004-0","article-title":"MicroRNA function in the nervous system","volume":"102","author":"Fiore","year":"2011","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2018.04.014_bib0285","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.conb.2009.09.006","article-title":"MicroRNAs in brain development and physiology","volume":"19","author":"Coolen","year":"2009","journal-title":"Curr. Opin. Neurobiol."},{"issue":"1652","key":"10.1016\/j.phrs.2018.04.014_bib0290","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2013.0515","article-title":"MicroRNAs and synaptic plasticity\u2013a mutual relationship","volume":"369","author":"Aksoy-Aksel","year":"2014","journal-title":"Philos. Trans. R Soc. Lond. B Biol. Sci."},{"issue":"9","key":"10.1016\/j.phrs.2018.04.014_bib0295","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1101\/lm.026492.112","article-title":"MicroRNAs in learning, memory, and neurological diseases","volume":"19","author":"Wang","year":"2012","journal-title":"Learn. Mem."},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0300","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.nbd.2012.02.016","article-title":"MicroRNA dysregulation in neuropsychiatric disorders and cognitive dysfunction","volume":"46","author":"Xu","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0305","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1471-4159.2010.07097.x","article-title":"I n vivo regulation of amyloid precursor protein neuronal splicing by microRNAs","volume":"116","author":"Smith","year":"2011","journal-title":"J. Neurochem."},{"issue":"24","key":"10.1016\/j.phrs.2018.04.014_bib0310","doi-asserted-by":"crossref","first-page":"18344","DOI":"10.1074\/jbc.M110.112664","article-title":"MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons","volume":"285","author":"Vilardo","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0315","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.neurobiolaging.2010.04.034","article-title":"MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer\u2019s-associated pathogenesis in SAMP8 mice","volume":"33","author":"Liu","year":"2012","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0320","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1074\/jbc.M807530200","article-title":"MicroRNA-298 and microRNA-328 regulate expression of mouse beta-amyloid precursor protein-converting enzyme 1","volume":"284","author":"Boissonneault","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2018.04.014_bib0325","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1523\/JNEUROSCI.5065-07.2008","article-title":"The expression of microRNA miR-107 decreases early in Alzheimer\u2019s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"issue":"17","key":"10.1016\/j.phrs.2018.04.014_bib0330","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","article-title":"Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression","volume":"105","author":"Hebert","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5842","key":"10.1016\/j.phrs.2018.04.014_bib0335","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1126\/science.1140481","article-title":"A MicroRNA feedback circuit in midbrain dopamine neurons","volume":"317","author":"Kim","year":"2007","journal-title":"Science"},{"issue":"15","key":"10.1016\/j.phrs.2018.04.014_bib0340","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/hmg\/ddr210","article-title":"MicroRNA profiling of Parkinson\u2019s disease brains identifies early downregulation of miR-34b\/c which modulate mitochondrial function","volume":"20","author":"Minones-Moyano","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2018.04.014_bib0345","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1038\/cddis.2013.73","article-title":"Influence of microRNA deregulation on chaperone-mediated autophagy and alpha-synuclein pathology in Parkinson\u2019s disease","volume":"4","author":"Alvarez-Erviti","year":"2013","journal-title":"Cell. Death. Dis."},{"issue":"12","key":"10.1016\/j.phrs.2018.04.014_bib0350","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.biocel.2004.02.013","article-title":"Mechanisms of chaperone-mediated autophagy","volume":"36","author":"Majeski","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"31","key":"10.1016\/j.phrs.2018.04.014_bib0355","doi-asserted-by":"crossref","first-page":"10820","DOI":"10.1073\/pnas.0800658105","article-title":"Huntington\u2019s disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies","volume":"105","author":"Savas","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"53","key":"10.1016\/j.phrs.2018.04.014_bib0360","doi-asserted-by":"crossref","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","article-title":"The bifunctional microRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in Huntington\u2019s disease","volume":"28","author":"Packer","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2018.04.014_bib0365","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.phrs.2016.05.005","article-title":"Circulating microRNAs in Huntington\u2019s disease: emerging mediators in metabolic impairment","volume":"108","author":"Diez-Planelles","year":"2016","journal-title":"Pharmacol. Res."},{"issue":"9","key":"10.1016\/j.phrs.2018.04.014_bib0370","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1101\/gr.135350.111","article-title":"GENCODE: the reference human genome annotation for The ENCODE Project","volume":"22","author":"Harrow","year":"2012","journal-title":"Genome Res."},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0375","doi-asserted-by":"crossref","first-page":"e1002917","DOI":"10.1371\/journal.pcbi.1002917","article-title":"The vast, conserved mammalian lincRNome","volume":"9","author":"Managadze","year":"2013","journal-title":"PLoS Comput. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2018.04.014_bib0380","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1101\/gr.132159.111","article-title":"The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression","volume":"22","author":"Derrien","year":"2012","journal-title":"Genome Res."},{"key":"10.1016\/j.phrs.2018.04.014_bib0385","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.brainresbull.2013.06.001","article-title":"Roles of long noncoding RNAs in brain development, functional diversification and neurodegenerative diseases","volume":"97","author":"Wu","year":"2013","journal-title":"Brain Res. Bull."},{"issue":"7364","key":"10.1016\/j.phrs.2018.04.014_bib0390","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature10398","article-title":"lincRNAs act in the circuitry controlling pluripotency and differentiation","volume":"477","author":"Guttman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2018.04.014_bib0395","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3389\/fncel.2017.00175","article-title":"Regulatory roles of long non-coding RNAs in the central nervous system and associated neurodegenerative diseases","volume":"11","author":"Quan","year":"2017","journal-title":"Front. Cell. Neurosci."},{"issue":"5","key":"10.1016\/j.phrs.2018.04.014_bib0400","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.neuron.2015.09.045","article-title":"Mechanisms of long non-coding RNAs in mammalian nervous system development, plasticity, disease, and evolution","volume":"88","author":"Briggs","year":"2015","journal-title":"Neuron"},{"issue":"24","key":"10.1016\/j.phrs.2018.04.014_bib0405","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1038\/emboj.2013.245","article-title":"Transcriptome sequencing during mouse brain development identifies long non-coding RNAs functionally involved in neurogenic commitment","volume":"32","author":"Aprea","year":"2013","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0410","doi-asserted-by":"crossref","first-page":"e995524","DOI":"10.1080\/23262133.2014.995524","article-title":"Identification and expression patterns of novel long non-coding RNAs in neural progenitors of the developing mammalian cortex","volume":"2","author":"Aprea","year":"2015","journal-title":"Neurogenesis (Austin)"},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0415","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3892\/mmr.2014.2351","article-title":"Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1AS expression","volume":"10","author":"Liu","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"7","key":"10.1016\/j.phrs.2018.04.014_bib0420","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nm1784","article-title":"Expression of a noncoding RNA is elevated in Alzheimer\u2019s disease and drives rapid feed-forward regulation of beta-secretase","volume":"14","author":"Faghihi","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2018.04.014_bib0425","doi-asserted-by":"crossref","first-page":"929042","DOI":"10.4061\/2011\/929042","article-title":"Knockdown of BACE1-AS nonprotein-coding transcript modulates beta-amyloid-related hippocampal neurogenesis","volume":"2011","author":"Modarresi","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"issue":"52","key":"10.1016\/j.phrs.2018.04.014_bib0430","doi-asserted-by":"crossref","first-page":"45093","DOI":"10.1074\/jbc.M111.310250","article-title":"Identification of novel GDNF isoforms and cis-antisense GDNFOS gene and their regulation in human middle temporal gyrus of Alzheimer disease","volume":"286","author":"Airavaara","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0435","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1007\/s12035-016-9793-6","article-title":"The role of long noncoding RNAs in neurodegenerative diseases","volume":"54","author":"Wan","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"25","key":"10.1016\/j.phrs.2018.04.014_bib0440","doi-asserted-by":"crossref","first-page":"10679","DOI":"10.1073\/pnas.0701532104","article-title":"Dendritic BC200 RNA in aging and in Alzheimer\u2019s disease","volume":"104","author":"Mus","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0445","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1471-4159.2007.05138.x","article-title":"SYNCRIP, a component of dendritically localized mRNPs, binds to the translation regulator BC200 RNA","volume":"105","author":"Duning","year":"2008","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0450","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0022-2836(02)00655-1","article-title":"Poly(A)-binding protein is associated with neuronal BC1 and BC200 ribonucleoprotein particles","volume":"321","author":"Muddashetty","year":"2002","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0455","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1007\/s12035-016-9854-x","article-title":"Altered long noncoding RNA expression precedes the course of parkinson\u2019s disease-a preliminary report","volume":"54","author":"Kraus","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.phrs.2018.04.014_bib0460","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s11033-016-4054-3","article-title":"The roles of non-coding RNAs in Parkinson\u2019s disease","volume":"43","author":"Majidinia","year":"2016","journal-title":"Mol. Biol. Rep."},{"issue":"7424","key":"10.1016\/j.phrs.2018.04.014_bib0465","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nature11508","article-title":"Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat","volume":"491","author":"Carrieri","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2018.04.014_bib0470","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fncel.2015.00114","article-title":"Expression analysis of the long non-coding RNA antisense to Uchl1 (AS Uchl1) during dopaminergic cells\u2019 differentiation in vitro and in neurochemical models of Parkinson\u2019s disease","volume":"9","author":"Carrieri","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"15","key":"10.1016\/j.phrs.2018.04.014_bib0475","doi-asserted-by":"crossref","first-page":"24449","DOI":"10.18632\/oncotarget.15511","article-title":"The long noncoding RNA HOTAIR promotes Parkinson\u2019s disease by upregulating LRRK2 expression","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0480","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/1567202613666160316155228","article-title":"Long non-coding RNA HOTAIR promotes parkinson\u2019s disease induced by MPTP through up-regulating the expression of LRRK2","volume":"13","author":"Liu","year":"2016","journal-title":"Curr. Neurovasc. Res."},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0485","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nbd.2011.12.006","article-title":"Long non-coding RNAs in Huntington\u2019s disease neurodegeneration","volume":"46","author":"Johnson","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"35","key":"10.1016\/j.phrs.2018.04.014_bib0490","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1038\/sj.onc.1205699","article-title":"5-Azacytidine and 5-aza-2\u2019-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy","volume":"21","author":"Christman","year":"2002","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0495","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0022-2836(02)00676-9","article-title":"Zebularine: a novel DNA methylation inhibitor that forms a covalent complex with DNA methyltransferases","volume":"321","author":"Zhou","year":"2002","journal-title":"J. Mol. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2018.04.014_bib0500","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1021\/jm7015705","article-title":"Constrained analogues of procaine as novel small molecule inhibitors of DNA methyltransferase-1","volume":"51","author":"Castellano","year":"2008","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2018.04.014_bib0505","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1101\/gad.1524107","article-title":"Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells","volume":"21","author":"Tan","year":"2007","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0510","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1124\/mol.104.008367","article-title":"Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids","volume":"68","author":"Lee","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0515","doi-asserted-by":"crossref","DOI":"10.3390\/biom7010003","article-title":"DNA methylation targeting: the DNMT\/HMT crosstalk challenge","volume":"7","author":"Castillo-Aguilera","year":"2017","journal-title":"Biomolecules"},{"issue":"7","key":"10.1016\/j.phrs.2018.04.014_bib0520","doi-asserted-by":"crossref","first-page":"422","DOI":"10.3816\/CGC.2007.n.029","article-title":"Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy","volume":"5","author":"Amato","year":"2007","journal-title":"Clin. Genitourin. Cancer"},{"issue":"14","key":"10.1016\/j.phrs.2018.04.014_bib0525","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1158\/0008-5472.CAN-04-2957","article-title":"Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases","volume":"65","author":"Brueckner","year":"2005","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0530","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molcel.2007.01.017","article-title":"Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase","volume":"25","author":"Kubicek","year":"2007","journal-title":"Mol. Cell"},{"issue":"7427","key":"10.1016\/j.phrs.2018.04.014_bib0535","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0540","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/1535-7163.MCT-13-0773","article-title":"Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma","volume":"13","author":"Knutson","year":"2014","journal-title":"Mol. Cancer Ther."},{"issue":"15","key":"10.1016\/j.phrs.2018.04.014_bib0545","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1016\/j.bmcl.2008.06.026","article-title":"Pyrazole inhibitors of coactivator associated arginine methyltransferase 1 (CARM1)","volume":"18","author":"Purandare","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.phrs.2018.04.014_bib0550","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.1074\/jbc.M109.063933","article-title":"Identification of a novel inhibitor of coactivator-associated arginine methyltransferase 1 (CARM1)-mediated methylation of histone H3 Arg-17","volume":"285","author":"Selvi","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0555","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nchembio.1810","article-title":"A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models","volume":"11","author":"Chan-Penebre","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"23","key":"10.1016\/j.phrs.2018.04.014_bib0560","doi-asserted-by":"crossref","first-page":"23892","DOI":"10.1074\/jbc.M401853200","article-title":"Small molecule regulators of protein arginine methyltransferases","volume":"279","author":"Cheng","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.phrs.2018.04.014_bib0565","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1021\/jm061250e","article-title":"Target-based approach to inhibitors of histone arginine methyltransferases","volume":"50","author":"Spannhoff","year":"2007","journal-title":"J. Med. Chem."},{"issue":"15","key":"10.1016\/j.phrs.2018.04.014_bib0570","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1016\/j.bmcl.2007.05.088","article-title":"A novel arginine methyltransferase inhibitor with cellular activity","volume":"17","author":"Spannhoff","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"16","key":"10.1016\/j.phrs.2018.04.014_bib0575","doi-asserted-by":"crossref","first-page":"6028","DOI":"10.1021\/jm100416n","article-title":"Discovery and mechanistic study of a class of protein arginine methylation inhibitors","volume":"53","author":"Feng","year":"2010","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0580","first-page":"971","article-title":"Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo","volume":"7","author":"Vigushin","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"28","key":"10.1016\/j.phrs.2018.04.014_bib0585","doi-asserted-by":"crossref","first-page":"17174","DOI":"10.1016\/S0021-9258(17)44885-X","article-title":"Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A","volume":"265","author":"Yoshida","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0590","first-page":"187","article-title":"SAHA, a HDAC inhibitor, has profound anti-growth activity against non-small cell lung cancer cells","volume":"15","author":"Komatsu","year":"2006","journal-title":"Oncol. Rep."},{"issue":"17","key":"10.1016\/j.phrs.2018.04.014_bib0595","first-page":"4916","article-title":"FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases","volume":"62","author":"Furumai","year":"2002","journal-title":"Cancer Res."},{"issue":"24","key":"10.1016\/j.phrs.2018.04.014_bib0600","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1093\/emboj\/20.24.6969","article-title":"Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells","volume":"20","author":"Gottlicher","year":"2001","journal-title":"EMBO J."},{"issue":"12","key":"10.1016\/j.phrs.2018.04.014_bib0605","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.freeradbiomed.2007.03.007","article-title":"St Clair DK Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury","volume":"42","author":"Daosukho","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0610","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0092-8674(78)90305-7","article-title":"Sodium butyrate inhibits histone deacetylation in cultured cells","volume":"14","author":"Candido","year":"1978","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.phrs.2018.04.014_bib0615","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.96.8.4592","article-title":"A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors","volume":"96","author":"Saito","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0620","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3727\/096504005775082066","article-title":"In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines","volume":"15","author":"Loprevite","year":"2005","journal-title":"Oncol. Res."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0625","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/excr.1998.4027","article-title":"FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor","volume":"241","author":"Nakajima","year":"1998","journal-title":"Exp. Cell Res."},{"issue":"5","key":"10.1016\/j.phrs.2018.04.014_bib0630","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2217\/fon.09.36","article-title":"Panobinostat (LBH589): a potent pan-deacetylase inhibitor with promising activity against hematologic and solid tumors","volume":"5","author":"Prince","year":"2009","journal-title":"Future Oncol."},{"issue":"8","key":"10.1016\/j.phrs.2018.04.014_bib0635","doi-asserted-by":"crossref","first-page":"e71323","DOI":"10.1371\/journal.pone.0071323","article-title":"A selective HDAC 1\/2 inhibitor modulates chromatin and gene expression in brain and alters mouse behavior in two mood-related tests","volume":"8","author":"Schroeder","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2018.04.014_bib0640","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bcp.2016.03.010","article-title":"HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264. 7 macrophages and mouse precision-cut lung slices by attenuating NF-kappaB p65 transcriptional activity","volume":"108","author":"Leus","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2018.04.014_bib0645","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1182\/blood-2011-10-387365","article-title":"Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma","volume":"119","author":"Santo","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0650","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/npp.2013.207","article-title":"Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability","volume":"39","author":"Jochems","year":"2014","journal-title":"Neuropsychopharmacology"},{"issue":"31","key":"10.1016\/j.phrs.2018.04.014_bib0655","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0660","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1097-2765(00)80452-9","article-title":"HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF","volume":"5","author":"Lau","year":"2000","journal-title":"Mol. Cell"},{"issue":"21","key":"10.1016\/j.phrs.2018.04.014_bib0665","doi-asserted-by":"crossref","first-page":"19134","DOI":"10.1074\/jbc.M301580200","article-title":"Small molecule modulators of histone acetyltransferase p300","volume":"278","author":"Balasubramanyam","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.phrs.2018.04.014_bib0670","doi-asserted-by":"crossref","first-page":"33716","DOI":"10.1074\/jbc.M402839200","article-title":"Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"49","key":"10.1016\/j.phrs.2018.04.014_bib0675","doi-asserted-by":"crossref","first-page":"51163","DOI":"10.1074\/jbc.M409024200","article-title":"Curcumin, a novel p300\/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone\/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription","volume":"279","author":"Balasubramanyam","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.phrs.2018.04.014_bib0680","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1002\/anie.200453879","article-title":"Design, synthesis, and biological evaluation of a small-molecule inhibitor of the histone acetyltransferase Gcn5","volume":"43","author":"Biel","year":"2004","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"10","key":"10.1016\/j.phrs.2018.04.014_bib0685","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1158\/1535-7163.MCT-05-0135","article-title":"Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity","volume":"4","author":"Stimson","year":"2005","journal-title":"Mol. Cancer Ther."},{"issue":"36","key":"10.1016\/j.phrs.2018.04.014_bib0690","doi-asserted-by":"crossref","first-page":"24453","DOI":"10.1074\/jbc.M109.023861","article-title":"Inhibition of lysine acetyltransferase KAT3B\/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin","volume":"284","author":"Ravindra","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0695","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.chembiol.2007.04.011","article-title":"Specific inhibition of p300-HAT alters global gene expression and represses HIV replication","volume":"14","author":"Mantelingu","year":"2007","journal-title":"Chem. Biol."},{"issue":"11","key":"10.1016\/j.phrs.2018.04.014_bib0700","doi-asserted-by":"crossref","first-page":"7702","DOI":"10.1074\/jbc.M113.486522","article-title":"Naphthoquinone-mediated inhibition of lysine acetyltransferase KAT3B\/p300, basis for non-toxic inhibitor synthesis","volume":"289","author":"Vasudevarao","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0705","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1021\/cb4000597","article-title":"Probing p300\/CBP associated factor (PCAF)-dependent pathways with a small molecule inhibitor","volume":"8","author":"Modak","year":"2013","journal-title":"ACS Chem. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2018.04.014_bib0710","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.chembiol.2010.03.006","article-title":"Virtual ligand screening of the p300\/CBP histone acetyltransferase: identification of a selective small molecule inhibitor","volume":"17","author":"Bowers","year":"2010","journal-title":"Chem. Biol."},{"issue":"7674","key":"10.1016\/j.phrs.2018.04.014_bib0715","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature24028","article-title":"Discovery of a selective catalytic p300\/CBP inhibitor that targets lineage-specific tumours","volume":"550","author":"Lasko","year":"2017","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.phrs.2018.04.014_bib0720","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1016\/j.bmcl.2008.04.017","article-title":"Identification of long chain alkylidenemalonates as novel small molecule modulators of histone acetyltransferases","volume":"18","author":"Sbardella","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0725","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/cbic.200900721","article-title":"The identification of a novel natural activator of p300 histone acetyltranferase provides new insights into the modulation mechanism of this enzyme","volume":"11","author":"Dal Piaz","year":"2010","journal-title":"Chembiochem"},{"issue":"26","key":"10.1016\/j.phrs.2018.04.014_bib0730","doi-asserted-by":"crossref","first-page":"10698","DOI":"10.1523\/JNEUROSCI.5772-12.2013","article-title":"A novel activator of CBP\/p300 acetyltransferases promotes neurogenesis and extends memory duration in adult mice","volume":"33","author":"Chatterjee","year":"2013","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0735","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ijc.23607","article-title":"Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine","volume":"123","author":"Stresemann","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"22","key":"10.1016\/j.phrs.2018.04.014_bib0740","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1073\/pnas.81.22.6993","article-title":"Covalent bond formation between a DNA-cytosine methyltransferase and DNA containing 5-azacytosine","volume":"81","author":"Santi","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2018.04.014_bib0745","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4137\/GEG.S12270","article-title":"Use of epigenetic drugs in disease: an overview","volume":"6","author":"Heerboth","year":"2014","journal-title":"Genet. Epigenet."},{"issue":"5","key":"10.1016\/j.phrs.2018.04.014_bib0750","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/bcpt.12514","article-title":"Pharmacokinetics of the experimental non-Nucleosidic DNA methyl transferase inhibitor N-Phthalyl-L-Tryptophan (RG 108) in rats","volume":"118","author":"Schneeberger","year":"2016","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0755","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1517\/13543784.2016.1144747","article-title":"Small molecule inhibitors of protein arginine methyltransferases","volume":"25","author":"Hu","year":"2016","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0760","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1517\/13543776.2014.877446","article-title":"Small-molecule inhibitors of histone deacetylase for the treatment of cancer and non-cancer diseases: a patent review (2011\u20132013)","volume":"24","author":"Valente","year":"2014","journal-title":"Expert. Opin. Ther. Pat."},{"issue":"10","key":"10.1016\/j.phrs.2018.04.014_bib0765","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0770","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00432-015-2026-y","article-title":"Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents","volume":"142","author":"Xue","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0775","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7164\/antibiotics.47.301","article-title":"FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968. I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity","volume":"47","author":"Ueda","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"10","key":"10.1016\/j.phrs.2018.04.014_bib0780","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"issue":"3-4","key":"10.1016\/j.phrs.2018.04.014_bib0785","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13148-010-0012-4","article-title":"Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy","volume":"1","author":"Wagner","year":"2010","journal-title":"Clin. Epigenet."},{"issue":"5","key":"10.1016\/j.phrs.2018.04.014_bib0790","first-page":"296","article-title":"Panobinostat (Farydak): a novel option for the treatment of relapsed or relapsed and refractory multiple myeloma","volume":"41","author":"Moore","year":"2016","journal-title":"P T"},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0795","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejmech.2011.11.001","article-title":"6-Alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site","volume":"47","author":"Ghizzoni","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"20","key":"10.1016\/j.phrs.2018.04.014_bib0800","doi-asserted-by":"crossref","first-page":"4670","DOI":"10.1002\/cncr.25414","article-title":"Development of curcumin as an epigenetic agent","volume":"116","author":"Fu","year":"2010","journal-title":"Cancer"},{"issue":"16","key":"10.1016\/j.phrs.2018.04.014_bib0805","doi-asserted-by":"crossref","first-page":"22623","DOI":"10.18632\/oncotarget.8033","article-title":"Oridonin, a novel lysine acetyltransferases inhibitor, inhibits proliferation and induces apoptosis in gastric cancer cells through p53- and caspase-3-mediated mechanisms","volume":"7","author":"Shi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phrs.2018.04.014_bib0810","doi-asserted-by":"crossref","first-page":"31022","DOI":"10.1038\/srep31022","article-title":"Inhibition of DNA methyltransferases blocks mutant huntingtin-induced neurotoxicity","volume":"6","author":"Pan","year":"2016","journal-title":"Sci. Rep."},{"issue":"46","key":"10.1016\/j.phrs.2018.04.014_bib0815","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.1523\/JNEUROSCI.1639-11.2011","article-title":"Epigenetic regulation of motor neuron cell death through DNA methylation","volume":"31","author":"Chestnut","year":"2011","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0820","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s13311-013-0226-1","article-title":"Small molecule inhibitors of zinc-dependent histone deacetylases","volume":"10","author":"Wagner","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0825","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington\u2019s disease","volume":"100","author":"Hockly","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0830","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12868-016-0264-9","article-title":"Histone deacetylase inhibitor SAHA attenuates post-seizure hippocampal microglia TLR4\/MYD88 signaling and inhibits TLR4 gene expression via histone acetylation","volume":"17","author":"Hu","year":"2016","journal-title":"BMC Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0835","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.expneurol.2011.06.003","article-title":"Treatment with trichostatin A initiated after disease onset delays disease progression and increases survival in a mouse model of amyotrophic lateral sclerosis","volume":"231","author":"Yoo","year":"2011","journal-title":"Exp. Neurol."},{"issue":"28","key":"10.1016\/j.phrs.2018.04.014_bib0840","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice","volume":"23","author":"Ferrante","year":"2003","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0845","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-2011-110080","article-title":"Sodium butyrate improves memory function in an Alzheimer\u2019s disease mouse model when administered at an advanced stage of disease progression","volume":"26","author":"Govindarajan","year":"2011","journal-title":"J. Alzheimers Dis."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0850","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pbb.2009.08.001","article-title":"Valproate ameliorates the survival and the motor performance in a transgenic mouse model of Huntington\u2019s disease","volume":"94","author":"Zadori","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0855","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/j.1471-4159.2004.02406.x","article-title":"Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction","volume":"89","author":"Ren","year":"2004","journal-title":"J. Neurochem."},{"issue":"2","key":"10.1016\/j.phrs.2018.04.014_bib0860","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1586\/14737175.2.2.151","article-title":"Valproate: a practical review of its uses in neurological and psychiatric disorders","volume":"2","author":"Kanner","year":"2002","journal-title":"Expert Rev. Neurother."},{"issue":"256","key":"10.1016\/j.phrs.2018.04.014_bib0865","doi-asserted-by":"crossref","first-page":"256ra135","DOI":"10.1126\/scitranslmed.3009278","article-title":"Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome","volume":"6","author":"Bjornsson","year":"2014","journal-title":"Sci. Transl. Med."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0870","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1074\/jbc.M410210200","article-title":"Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington\u2019s disease","volume":"280","author":"Gardian","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0875","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jep.2009.09.056","article-title":"Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer\u2019s disease model","volume":"127","author":"Uabundit","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2018.04.014_bib0880","doi-asserted-by":"crossref","first-page":"945217","DOI":"10.1155\/2015\/945217","article-title":"Molecular and functional characterization of bacopa monniera: a retrospective review","volume":"2015","author":"Rajan","year":"2015","journal-title":"Evidence Based Complement Altern. Med."},{"issue":"7","key":"10.1016\/j.phrs.2018.04.014_bib0885","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1089\/acm.2009.0342","article-title":"Does Bacopa monnieri improve memory performance in older persons? Results of a randomized, placebo-controlled, double-blind trial","volume":"16","author":"Morgan","year":"2010","journal-title":"J. Altern. Complement. Med."},{"issue":"12","key":"10.1016\/j.phrs.2018.04.014_bib0890","doi-asserted-by":"crossref","first-page":"e1001240","DOI":"10.1371\/journal.pgen.1001240","article-title":"Histone deacetylases suppress CGG repeat-induced neurodegeneration via transcriptional silencing in models of fragile X tremor ataxia syndrome","volume":"6","author":"Todd","year":"2010","journal-title":"PLoS Genet."},{"issue":"7","key":"10.1016\/j.phrs.2018.04.014_bib0895","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.M404751200","article-title":"Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo","volume":"280","author":"Yang","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.phrs.2018.04.014_bib0900","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1002\/ptr.2940","article-title":"Neuroprotective effect of luteolin on amyloid beta protein (25\u201335)-induced toxicity in cultured rat cortical neurons","volume":"24","author":"Cheng","year":"2010","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0905","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1073\/pnas.1611431114","article-title":"A ketogenic diet rescues hippocampal memory defects in a mouse model of Kabuki syndrome","volume":"114","author":"Benjamin","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6","key":"10.1016\/j.phrs.2018.04.014_bib0910","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","article-title":"Chromatin acetylation, memory, and LTP are impaired in CBP+\/\u2212 mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration","volume":"42","author":"Alarcon","year":"2004","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.phrs.2018.04.014_bib0915","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s13670-012-0027-0","article-title":"Epigenetics-based therapeutics for neurodegenerative disorders","volume":"1","author":"Xu","year":"2012","journal-title":"Curr. Transl. Geriatr. Exp. Gerontol. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2018.04.014_bib0920","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/acn3.147","article-title":"The promise and perils of HDAC inhibitors in neurodegeneration","volume":"2","author":"Didonna","year":"2015","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.phrs.2018.04.014_bib0925","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fncel.2013.00030","article-title":"Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities","volume":"7","author":"Pirooznia","year":"2013","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0930","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.braindev.2011.04.010","article-title":"Valproic acid increases SMN2 expression and modulates SF2\/ASF and hnRNPA1 expression in SMA fibroblast cell lines","volume":"34","author":"Harahap","year":"2012","journal-title":"Brain Dev."},{"issue":"12","key":"10.1016\/j.phrs.2018.04.014_bib0935","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.bbadis.2013.08.005","article-title":"Spinal muscular atrophy: an update on therapeutic progress","volume":"1832","author":"Seo","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"11","key":"10.1016\/j.phrs.2018.04.014_bib0940","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1093\/hmg\/6.11.1771","article-title":"Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes","volume":"6","author":"Campuzano","year":"1997","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.phrs.2018.04.014_bib0945","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.nbd.2011.02.016","article-title":"Prolonged treatment with pimelic o-aminobenzamide HDAC inhibitors ameliorates the disease phenotype of a Friedreich ataxia mouse model","volume":"42","author":"Sandi","year":"2011","journal-title":"Neurobiol. Dis."},{"issue":"17","key":"10.1016\/j.phrs.2018.04.014_bib0950","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1021\/jp067655s","article-title":"Activation of p300 histone acetyltransferase by small molecules altering enzyme structure: probed by surface-enhanced Raman spectroscopy","volume":"111","author":"Mantelingu","year":"2007","journal-title":"J. Phys. Chem. B"},{"issue":"10\u201312","key":"10.1016\/j.phrs.2018.04.014_bib0955","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bbagrm.2010.08.012","article-title":"Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases","volume":"1799","author":"Selvi","year":"2010","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817316924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817316924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T05:47:28Z","timestamp":1720244848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817316924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":191,"alternative-id":["S1043661817316924"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2018.04.014","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic modulation by small molecule compounds for neurodegenerative disorders","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2018.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}